Form 8-K - Current report:
SEC Accession No. 0001181431-14-032198
Filing Date
2014-09-17
Accepted
2014-09-17 15:35:58
Documents
2
Period of Report
2014-09-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rrd416383.htm 8-K 12815
2 PRESS RELEASE, DATED SEPTEMBER 17, 2014 rrd416383_40815.htm EX-99 9379
  Complete submission text file 0001181431-14-032198.txt   23611
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35560 | Film No.: 141107697
SIC: 2834 Pharmaceutical Preparations